[PDF][PDF] Differential In Vivo Effects on Target Pathways of a Novel Arylpyrazole Glucocorticoid Receptor Modulator Compared with PrednisoloneDS
DJ Roohk, KA Varady, SM Turner… - THE JOURNAL OF …, 2010 - academia.edu
Glucocorticoids are widely prescribed to treat autoimmune and inflammatory diseases.
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
Differential in vivo effects on target pathways of a novel arylpyrazole glucocorticoid receptor modulator compared with prednisolone
DJ Roohk, KA Varady, SM Turner… - Journal of …, 2010 - ohsu.elsevierpure.com
Glucocorticoids are widely prescribed to treat autoimmune and inflammatory diseases.
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
Differential in vivo effects on target pathways of a novel arylpyrazole glucocorticoid receptor modulator compared with prednisolone
DJ Roohk, KA Varady, SM Turner… - The Journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Glucocorticoids are widely prescribed to treat autoimmune and inflammatory diseases.
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
Differential in vivo effects on target pathways of a novel arylpyrazole glucocorticoid receptor modulator compared with prednisolone
DJ Roohk, KA Varady, SM Turner, CL Emson… - … of Pharmacology and …, 2010 - hero.epa.gov
Glucocorticoids are widely prescribed to treat autoimmune and inflammatory diseases.
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
[PDF][PDF] Differential In Vivo Effects on Target Pathways of a Novel Arylpyrazole Glucocorticoid Receptor Modulator Compared with Prednisolone DS
DJ Roohk, KA Varady, SM Turner, CL Emson… - THE JOURNAL OF …, 2010 - leshipp.com
Glucocorticoids are widely prescribed to treat autoimmune and inflammatory diseases.
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
[PDF][PDF] Differential In Vivo Effects on Target Pathways of a Novel Arylpyrazole Glucocorticoid Receptor Modulator Compared with Prednisolone DS
DJ Roohk, KA Varady, SM Turner… - THE JOURNAL OF …, 2010 - researchgate.net
Glucocorticoids are widely prescribed to treat autoimmune and inflammatory diseases.
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
Differential in vivo effects on target pathways of a novel arylpyrazole glucocorticoid receptor modulator compared with prednisolone.
DJ Roohk, KA Varady, SM Turner… - The Journal of …, 2010 - europepmc.org
Glucocorticoids are widely prescribed to treat autoimmune and inflammatory diseases.
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
[PDF][PDF] Differential In Vivo Effects on Target Pathways of a Novel Arylpyrazole Glucocorticoid Receptor Modulator Compared with PrednisoloneDS
DJ Roohk, KA Varady, SM Turner… - THE JOURNAL OF …, 2010 - academia.edu
Glucocorticoids are widely prescribed to treat autoimmune and inflammatory diseases.
Although they are extremely potent, their utility in clinical practice is limited by a variety of …
Although they are extremely potent, their utility in clinical practice is limited by a variety of …